CHICAGO, IL (October 17, 2019) RiverGlade Capital (“RiverGlade”), a healthcare-focused private equity firm, announced today the closing of its inaugural fund, RiverGlade Capital, L.P. (“the Fund”), with $325 million of commitments. Fund commitments exceeded the target size of $300 million.

RiverGlade’s founders and Managing Partners, Garrick Rice and Danny Rosenberg, have nearly two decades of investing together. The investment strategy remains focused on partnering with founders and management teams of exceptional healthcare companies. RiverGlade’s team will continue to pursue investments in the following healthcare sectors: multi-unit care models, outsourced services, tech-enabled services and medical products. RiverGlade’s target investments range in size from $25 million to $150 million in enterprise value.

About RiverGlade Capital

RiverGlade Capital is a healthcare-focused private equity firm that partners with founders and management teams to grow exceptional healthcare companies. RiverGlade invests in companies that have demonstrated strong organic growth and where value can be accelerated through human capital investments, operational improvements, strategic planning, and dynamic organic and inorganic growth initiatives. For more information,